Candel Therapeutics Inc (CADL)
8.90
+0.28
(+3.25%)
USD |
NASDAQ |
May 31, 16:00
9.00
+0.10
(+1.12%)
After-Hours: 20:00
Candel Therapeutics Accounts Payable (Quarterly): 0.472M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.472M |
December 31, 2023 | 0.422M |
September 30, 2023 | 0.25M |
June 30, 2023 | 0.48M |
March 31, 2023 | 0.592M |
December 31, 2022 | 0.38M |
September 30, 2022 | 0.97M |
Date | Value |
---|---|
June 30, 2022 | 1.584M |
March 31, 2022 | 1.386M |
December 31, 2021 | 1.59M |
September 30, 2021 | 0.925M |
June 30, 2021 | 0.759M |
March 31, 2021 | 1.513M |
December 31, 2020 | 0.921M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.25M
Minimum
Sep 2023
1.59M
Maximum
Dec 2021
0.8746M
Average
0.84M
Median
Accounts Payable (Quarterly) Benchmarks
Allurion Technologies Inc | 11.94M |
AngioDynamics Inc | 35.15M |
Eliem Therapeutics Inc | 0.085M |
Macrogenics Inc | 10.69M |
GlycoMimetics Inc | 0.7555M |